Preterm
127
31
36
58
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Research Maturity
58 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
2 terminated out of 127 trials
96.7%
+10.1% vs benchmark
3%
4 trials in Phase 3/4
3%
2 of 58 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 58 completed trials
Clinical Trials (127)
HEP® Tele-Rehabilitation for Preterm Infants at Developmental Risk: A Feasibility Study
Neonatal Diaphragmatic Activity-Linked Extubation Conditions and Timing
Preschool Outcomes of a Previous RCT - ReDiMOM (NCT04540575)
Dietary Pattern Intervention for Neurodevelopment in Preterm Infants
Early Childhood (2-year) Outcomes Among Former VLBW From the ReDiMOM Trial
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries- PreTerm
Effect of Maternal Voice on Physiological Indicators and Feeding Performance
Admission to Kangaroo Mother Care (KMC) Ward and Maternal Postpartum Depression
Sensory Optimization of the Hospital Environment
Thyroxine Supplementation in Small for Gestational Age (SGA) Infants With Birth Weight <1500g and TSH 6-20 mIU/ml
Improving Preterm Kidney Outcomes With Caffeine
Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
SAFE Early Intervention for At-Risk Infants
Assessing Intellectual and Motor Outcomes in High-risk Infants
Enhancing the Survival of Low Birth Weight Infants in Low-Resource Settings
Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.
Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).